Very interesting results were published by Zhang et al. in 2021, where they evaluated the diagnostic potential of SDC2 and Tissue Factor Pathway Inhibitor 2 (TFPI2) gene methylation analysis in stool samples as a biomarker for early detection of CRC. Here, SDC2 is linked to colorectal carcinoma.